Page last updated: 2024-10-23

biperiden and Cystic Fibrosis of Pancreas

biperiden has been researched along with Cystic Fibrosis of Pancreas in 1 studies

Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramachandran, S1
Osterhaus, SR1
Karp, PH1
Welsh, MJ1
McCray, PB1

Other Studies

1 other study available for biperiden and Cystic Fibrosis of Pancreas

ArticleYear
A genomic signature approach to rescue ΔF508-cystic fibrosis transmembrane conductance regulator biosynthesis and function.
    American journal of respiratory cell and molecular biology, 2014, Volume: 51, Issue:3

    Topics: Biperiden; Bronchi; Chlorides; Computational Biology; Cystic Fibrosis; Cystic Fibrosis Transmembrane

2014